Bioage Labs Is Maintained at Neutral by Citigroup

Dow JonesMar 24 10:52 ET

Bioage Labs Analyst Ratings

BenzingaMar 24 10:42 ET

Citigroup Maintains Neutral on Bioage Labs, Lowers Price Target to $5

BenzingaMar 24 10:42 ET

BioAge Labs, Inc.: Sell Rating Due to Discontinued Program and Uncertain Prospects

TipRanksMar 23 14:29 ET

Jefferies Downgrades BioAge Labs(BIOA.US) to Hold Rating, Cuts Target Price to $7

Moomoo NewsMar 21 22:31 ET

William Blair Maintains BioAge Labs(BIOA.US) With Hold Rating

Moomoo NewsMar 21 22:31 ET

William Blair Sticks to Its Hold Rating for BioAge Labs, Inc. (BIOA)

TipRanksMar 21 07:34 ET

Morgan Stanley Assumes Bioage Labs at Underweight, Announces Price Target of $5

BenzingaMar 7 12:12 ET

William Blair Maintains BioAge Labs(BIOA.US) With Hold Rating

Moomoo NewsMar 6 15:31 ET

William Blair Maintains BioAge Labs(BIOA.US) With Hold Rating

Moomoo NewsMar 5 17:31 ET

Bioage Labs Initiated at Market Perform by William Blair

Dow JonesFeb 28 07:15 ET

Bioage Labs Analyst Ratings

BenzingaFeb 28 07:05 ET

William Blair Initiates BioAge Labs(BIOA.US) With Hold Rating, Announces Target Price $10

Moomoo NewsFeb 27 16:32 ET

Citi Downgrades BioAge Labs(BIOA.US) to Hold Rating, Cuts Target Price to $7

Moomoo NewsJan 29 07:31 ET

Morgan Stanley Downgrades BioAge Labs(BIOA.US) to Sell Rating, Cuts Target Price to $5

Moomoo NewsJan 29 07:31 ET

BioAge Labs Faces Sell Rating Amid Safety Concerns and Uncertain Prospects

TipRanksJan 29 07:20 ET

BioAge Labs: Strategic Shifts and Developmental Progress Support Hold Rating Amidst Inherent Risks

TipRanksJan 29 06:48 ET

Morgan Stanley Downgrades BioAge Labs to Underweight From Overweight, Slashes Price Target to $5 From $40

MT NewswiresDec 10, 2024 06:23 ET

Citigroup Downgrades BioAge Labs to Neutral From Buy, Adjusts Price Target to $7 From $45

MT NewswiresDec 9, 2024 07:29 ET

Morgan Stanley Maintains BioAge Labs(BIOA.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsDec 9, 2024 06:31 ET